Skip to search formSkip to main contentSkip to account menu

Safinamide Mesylate

Known as: (S)-( )-2-(4-(3-Fluorobenzyloxy) benzylamino)propanamide, Methanesulfonate, Safinamide Mesilate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
▼ Safinamide (Xadago - Zambon S.p.A) is a monoamine-oxidase B (MAO-B) inhibitor licensed as add-on therapy for people with… 
Review
2018
Review
2018
  • D. HussarL. Finn
  • 2018
  • Corpus ID: 4560118
Five new drugs marketed within the last year, which are used for medical problems often experienced by the elderly, have been… 
2016
2016
The invention relates to a new safinamide mesylate crystal form named as form C and a preparation method thereof. An X-Ray powder… 
2016
2016
The invention relates to a method for preparing industrial safinamide mesylate, and belongs to the technical field of organic… 
2016
2016
The invention discloses a new crystal form of safinamide mesylate and a preparation method of the new crystal form. According to… 
2013
2013
A rapid, highly sensitive high performance liquid chromatographic method has been developed for the determination of Safinamide… 
2007
2007
Process for the production of 2- [4- (2- and 3- Fluorobenzyloxy) benzylamino] propanamides, Schiff base ISOLATED, OR RALFINAMIDA… 
Review
2004
Review
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…